Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation
Wisniewski, T.; Ghiso, J.; Frangione, B.
Biochemical and Biophysical Research Communications 180(3): 1528
1991
ISSN/ISBN: 0006-291X PMID: 1953795 DOI: 10.1016/s0006-291x(05)81370-1
Accession: 068553597
Full Text Article emailed within 0-6 h: $19.90
Related References
Wisniewski, T.; Ghiso, J.; Frangione, B. 1991: Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation Biochemical and Biophysical Research Communications 179(3): 1247-1254Maury, C.P.; Nurmiaho-Lassila, E.L.; Liljeström, M. 1997: Alzheimer's disease-associated presenilins 1 and 2: accelerated amyloid fibril formation of mutant 410 Cys-->Tyr and 141 Asn-->Ile peptides Biochemical and Biophysical Research Communications 235(1): 249-252
Goldgaber, D.; Vitek, M.P.; Tsiper, M.; Wente, H.; Wang, A.; Salles, F.J.; Schwarzman, A.L. 1996: Inhibition of beta-amyloid fibril formation by synthetic peptides homologous to transthyretin and amyloid beta protein Society for Neuroscience Abstracts 22(1-3): 1945
Gorevic, P.D.; Castano, E.M.; Sarma, R.; Frangione, B. 1987: Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern Biochemical and Biophysical Research Communications 147(2): 854-862
Castaño, E.M.; Ghiso, J.; Prelli, F.; Gorevic, P.D.; Migheli, A.; Frangione, B. 1986: In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein Biochemical and Biophysical Research Communications 141(2): 782-789
Maury, C.P.; Nurmiaho-Lassila, E.L.; Rossi, H. 1994: Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides Laboratory Investigation; A Journal of Technical Methods and Pathology 70(4): 558-564
Wiesehan, K.; Stöhr, J.; Nagel-Steger, L.; van Groen, T.; Riesner, D.; Willbold, D. 2008: Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide Protein Engineering Design and Selection: Peds 21(4): 241-246
Cottingham, M.G.; Hollinshead, M.S.; Vaux, D.J.T. 2002: Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide Biochemistry 41(46): 13539-13547
Cottingham, M.G.; Hollinshead, M.S.; Vaux, D.J.T. 2002: Amyloid Fibril Formation by a Synthetic Peptide from a Region of Human Acetylcholinesterase that Is Homologous to the Alzheimer s Amyloid-b Peptide Biochemistry (American Chemical Society) 41(46): 539-47
Arai, T.; Ohno, A.; Mori, K.; Kuwata, H.; Mizuno, M.; Imai, K.; Hara, S.; Shibanuma, M.; Kurihara, M.; Miyata, N.; Nakagawa, H.; Fukuhara, K. 2016: Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides Bioorganic and Medicinal Chemistry Letters 26(22): 5468-5471
Harper, J.D.; Lieber, C.M.; Lansbury, P.T. 1997: Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein Chemistry and Biology 4(12): 951-959
Kirschner, D.A.; Elliott-Bryant, R.; Szumowski, K.E.; Gonnerman, W.A.; Kindy, M.S.; Sipe, J.D.; Cathcart, E.S. 1998: In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice Journal of Structural Biology 124(1): 88-98
Chiba, T.; Hagihara, Y.; Higurashi, T.; Hasegawa, K.; Naiki, H.; Goto, Y. 2003: Amyloid fibril formation in the context of full-length protein: effects of proline mutations on the amyloid fibril formation of beta2-microglobulin Journal of Biological Chemistry 278(47): 47016-47024
Linke, R.P. 1982: Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease Clinical Neuropathology 1(4): 172-182
Chiba, T.; Hagihara, Y.; Higurashi, T. 2003: Amyloid Fibril Formation in the Context of Full-length Protein. Effects of Proline Mutations on the Amyloid Fibril Formation of b2-Microglobulin Journal of Biological Chemistry 278(47): 016-024
Higuchi, K.; Yonezu, T.; Tsunasawa, S.; Sakiyama, F.; Takeda, T. 1986: The single proline-glutamine substitution at position 5 enhances the potency of amyloid fibril formation of murine apo A-Ii Febs Letters 207(1): 23-27
Sultana, R.; Robinson, Rã.A.S.; Lange, M.Bader.; Fiorini, A.; Galvan, V.; Fombonne, J.; Baker, A.; Gorostiza, O.; Zhang, J.; Cai, J.; Pierce, W.M.; Bredesen, D.E.; Butterfield, D.Allan. 2012: Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis? Antioxidants and Redox Signaling 17(11): 1507-1514
Flood, J.F.; Morley, J.E.; Roberts, E. 1991: Amnestic effects in mice of four synthetic peptides homologous to amyloid b protein from patients with Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 88: 63-6
Lahiri, D.K.; Farlow, M.R.; Hintz, N.; Utsuki, T.; Greig, N.H. 2000: Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease Acta Neurologica Scandinavica 102(Suppl S176): 60-67
Wang, S.S-S.; Chen, Y-Ting.; Chou, S-Wei. 2005: Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants Biochimica et Biophysica Acta 1741(3): 307-313